Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Karin Ann Thacker brings 20 years of leadership experience.
August 27, 2020
By: Contract Pharma
Contract Pharma Staff
Harpoon Therapeutics Inc., a clinical-stage immunotherapy company developing a novel class of T cell engagers, has appointed Karin Ann Thacker, M.Sc., as vice president, regulatory affairs and quality assurance. Thacker joins Harpoon from Gritstone Oncology where she most recently served as vice president, global regulatory affairs. “I am pleased to welcome Karin Thacker to Harpoon’s executive management team to oversee our global regulatory affairs and quality assurance efforts,” said Gerald McMahon, Ph.D., president and chief executive officer of Harpoon Therapeutics. “Karin is a deeply experienced regulatory and quality assurance executive in the biopharma industry and I am confident she will contribute to the advancement of our TriTAC T cell engager pipeline programs as they continue to advance forward in clinical studies.” Thacker joins Harpoon with more than 20 years of leadership experience in regulatory affairs and quality assurance in the biopharmaceutical industry. At Gritstone, she built out the Regulatory Affairs function, served as the lead on two INDs, and provided regulatory strategic expertise on the development of personalized therapeutic cancer vaccines, bispecific antibodies, biomarkers and companion diagnostics. She also led FDA interactions on the design and quality systems for the company’s GMP bioinformatics and manufacturing facilities. Prior to Gritstone, she served as senior director, head of regulatory development, Global Regulatory Affairs at Puma Biotechnology. She has also held positions at Gilead Sciences, Sunesis Pharmaceuticals, Genitope Corporation, Chiron Corporation, and Sanofi Pasteur in roles of increasing responsibility. Thacker received her M.Sc., and B.Sc. (hons) degrees in microbiology from the University of Manitoba. “I am excited to join the team at Harpoon Therapeutics where there is an energy to do innovative work with the goal of impacting the treatment of cancer patients with advanced solid tumors and hematologic malignancies,” commented Thacker. “Harpoon has built an impressive and highly differentiated development pipeline, and I look forward to contributing to regulatory strategies to bring the potential of Harpoon’s drug candidates to their full medical and commercial potential.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !